Latest Breaking News On - Phanes therapeutics inc - Page 2 : comparemela.com

New Trial Combines PT886 And Keytruda for Gastric Cancer

A phase 1 trial is being conducted to evaluate the combination of PT886 and Keytruda in patients with claudin 18.2 positive gastric or gastroesophageal junction (GEJ) adenocarcinomas.

Ming-wang
Phanes-therapeutics-inc
National-institutes-of-health
National-institutes
Phanes-therapeutics
Clinical-trial
Gastric-cancer
Cancer-clinical-trial

Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)

Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Ming-wang
Phanes-therapeutics-inc
Merck-co-inc
Merck-sharp-dohme
Prnewswire-phanes-therapeutics-inc
Announces-clinical-trial-collaboration
Supply-agreement
Merck-sharp
Phanes-therapeutics

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shanghai
China
Israel
United-states
American
Chinese
Rita-laeufle
Opdivo-nivolumab
American-clinical-oncology-society
Md-anderson-cancer-center
Prnewswire-phanes-therapeutics-inc
Chinese-society-of-clinical-oncology

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

/PRNewswire/ Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today.

Israel
Shanghai
China
United-states
Chinese
American
Opdivo-nivolumab
Rita-laeufle
Technology-progress
Technology-award
Phanes-therapeutics-inc
Board-member-of-anticancer-association

Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3

Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ming-wang
Phanes-therapeutics-inc
Prnewswire-phanes-therapeutics-inc
Phanes-therapeutics